You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINDAMYCIN PALMITATE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Clindamycin Palmitate Hydrochloride patents expire, and when can generic versions of Clindamycin Palmitate Hydrochloride launch?

Clindamycin Palmitate Hydrochloride is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Chartwell Rx, Heritage Pharms Inc, Padagis Us, and Rising. and is included in seven NDAs.

The generic ingredient in CLINDAMYCIN PALMITATE HYDROCHLORIDE is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clindamycin Palmitate Hydrochloride

A generic version of CLINDAMYCIN PALMITATE HYDROCHLORIDE was approved as clindamycin palmitate hydrochloride by PADAGIS US on July 7th, 2010.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLINDAMYCIN PALMITATE HYDROCHLORIDE?
  • What are the global sales for CLINDAMYCIN PALMITATE HYDROCHLORIDE?
  • What is Average Wholesale Price for CLINDAMYCIN PALMITATE HYDROCHLORIDE?
Summary for CLINDAMYCIN PALMITATE HYDROCHLORIDE
Drug patent expirations by year for CLINDAMYCIN PALMITATE HYDROCHLORIDE

US Patents and Regulatory Information for CLINDAMYCIN PALMITATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 203513-001 Mar 13, 2014 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 203063-001 May 25, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Heritage Pharms Inc CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 207047-001 May 11, 2018 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Ltd CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 202409-001 Apr 30, 2013 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 206958-001 May 5, 2017 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 201821-001 Aug 28, 2012 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.